Annual ROE
45.26%
+1.90%+4.38%
31 December 2023
Summary:
ArriVent BioPharma Common Stock annual return on equity is currently 45.26%, with the most recent change of +1.90% (+4.38%) on 31 December 2023. AVBP annual ROE is now at all-time high.AVBP ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly ROE
-105.26%
-14.10%-15.47%
01 September 2024
Summary:
ArriVent BioPharma Common Stock quarterly return on equity is currently -105.26%, with the most recent change of -14.10% (-15.47%) on 01 September 2024. Over the past year, it has dropped by -659.98% (-118.98%). AVBP quarterly ROE is now -118.98% below its all-time high of 554.72%, reached on 30 September 2023.AVBP Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AVBP ROE Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +4.4% | -119.0% |
| 3 y3 years | - | - |
| 5 y5 years | - | - |
AVBP ROE High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +4.4% | -119.0% | +23.1% |
| 5 y | 5 years | at high | +4.4% | -119.0% | +23.1% |
| alltime | all time | at high | +4.4% | -119.0% | +23.1% |
ArriVent BioPharma Common Stock ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | -105.26%(+15.5%) |
| June 2024 | - | -91.16%(-33.4%) |
| Mar 2024 | - | -136.87%(-165.6%) |
| Dec 2023 | 45.26% | 208.49%(-62.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2023 | - | 554.72%(-600.3%) |
| June 2023 | - | -110.88%(-374.5%) |
| Mar 2023 | - | 40.40%(+54.8%) |
| Dec 2022 | 43.36% | - |
| Dec 2022 | - | 26.10% |
FAQ
- What is ArriVent BioPharma Common Stock annual return on equity?
- What is the all time high annual ROE for ArriVent BioPharma Common Stock?
- What is ArriVent BioPharma Common Stock annual ROE year-on-year change?
- What is ArriVent BioPharma Common Stock quarterly return on equity?
- What is the all time high quarterly ROE for ArriVent BioPharma Common Stock?
- What is ArriVent BioPharma Common Stock quarterly ROE year-on-year change?
What is ArriVent BioPharma Common Stock annual return on equity?
The current annual ROE of AVBP is 45.26%
What is the all time high annual ROE for ArriVent BioPharma Common Stock?
ArriVent BioPharma Common Stock all-time high annual return on equity is 45.26%
What is ArriVent BioPharma Common Stock annual ROE year-on-year change?
Over the past year, AVBP annual return on equity has changed by +1.90% (+4.38%)
What is ArriVent BioPharma Common Stock quarterly return on equity?
The current quarterly ROE of AVBP is -105.26%
What is the all time high quarterly ROE for ArriVent BioPharma Common Stock?
ArriVent BioPharma Common Stock all-time high quarterly return on equity is 554.72%
What is ArriVent BioPharma Common Stock quarterly ROE year-on-year change?
Over the past year, AVBP quarterly return on equity has changed by -659.98% (-118.98%)